361 related articles for article (PubMed ID: 32652144)
41. PTPN2 mutations cause epithelium-intrinsic barrier loss that synergizes with mucosal immune hyperactivation.
Sweat YY; Turner JR
J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623321
[TBL] [Abstract][Full Text] [Related]
42. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
[TBL] [Abstract][Full Text] [Related]
43. PTPN2 negatively regulates macrophage inflammation in atherosclerosis.
Hu X; Ma R; Cao J; Du X; Cai X; Fan Y
Aging (Albany NY); 2020 Dec; 13(2):2768-2779. PubMed ID: 33411686
[TBL] [Abstract][Full Text] [Related]
44. Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
Kang JW; Yan J; Ranjan K; Zhang X; Turner JR; Abraham C
Gastroenterology; 2020 Sep; 159(3):1051-1067. PubMed ID: 32693188
[TBL] [Abstract][Full Text] [Related]
45. Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression.
Kim MR; Cho SY; Lee HJ; Kim JY; Nguyen UTT; Ha NM; Choi KY; Cha KH; Kim JH; Kim WK; Kang K
Phytomedicine; 2022 Aug; 103():154209. PubMed ID: 35689901
[TBL] [Abstract][Full Text] [Related]
46. Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice.
Akbari P; Braber S; Alizadeh A; Verheijden KA; Schoterman MH; Kraneveld AD; Garssen J; Fink-Gremmels J
J Nutr; 2015 Jul; 145(7):1604-13. PubMed ID: 26019243
[TBL] [Abstract][Full Text] [Related]
47. Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel disease.
Al-Ghadban S; Kaissi S; Homaidan FR; Naim HY; El-Sabban ME
Sci Rep; 2016 Jul; 6():29783. PubMed ID: 27417573
[TBL] [Abstract][Full Text] [Related]
48. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
[TBL] [Abstract][Full Text] [Related]
49. Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice.
Marincola Smith P; Choksi YA; Markham NO; Hanna DN; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Yang J; Liu Q; Kaji I; Means AL; Beauchamp RD
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G936-G957. PubMed ID: 33759564
[TBL] [Abstract][Full Text] [Related]
50. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
[TBL] [Abstract][Full Text] [Related]
51. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.
Olivier S; Pochard C; Diounou H; Castillo V; Divoux J; Alcantara J; Leclerc J; Guilmeau S; Huet C; Charifi W; Varin TV; Daniel N; Foretz M; Neunlist M; Salomon BL; Ghosh P; Marette A; Rolli-Derkinderen M; Viollet B
Mol Metab; 2021 May; 47():101183. PubMed ID: 33548500
[TBL] [Abstract][Full Text] [Related]
52. A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease.
Rodríguez-Feo JA; Puerto M; Fernández-Mena C; Verdejo C; Lara JM; Díaz-Sánchez M; Álvarez E; Vaquero J; Marín-Jiménez I; Bañares R; Menchén L
Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G981-93. PubMed ID: 25907690
[TBL] [Abstract][Full Text] [Related]
53. IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.
Wang Y; Mumm JB; Herbst R; Kolbeck R; Wang Y
J Immunol; 2017 Nov; 199(9):3316-3325. PubMed ID: 28939759
[TBL] [Abstract][Full Text] [Related]
54. The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
Yilmaz B; Spalinger MR; Biedermann L; Franc Y; Fournier N; Rossel JB; Juillerat P; Rogler G; Macpherson AJ; Scharl M
PLoS One; 2018; 13(7):e0199664. PubMed ID: 29965986
[TBL] [Abstract][Full Text] [Related]
55. Epithelial CRL4
Zhang Y; Wang C; Wu L; Bai C; Huang K; Yao L; Zhang Z; Ye L; Liu R; Ge X; Xu M; Zhao Y; Cao Q
Dig Dis Sci; 2024 Jan; 69(1):66-80. PubMed ID: 37968554
[TBL] [Abstract][Full Text] [Related]
56. Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice.
Shi CZ; Chen HQ; Liang Y; Xia Y; Yang YZ; Yang J; Zhang JD; Wang SH; Liu J; Qin HL
World J Gastroenterol; 2014 Apr; 20(16):4636-47. PubMed ID: 24782616
[TBL] [Abstract][Full Text] [Related]
57. PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.
Spalinger MR; Kasper S; Chassard C; Raselli T; Frey-Wagner I; Gottier C; Lang S; Atrott K; Vavricka SR; Mair F; Becher B; Lacroix C; Fried M; Rogler G; Scharl M
Mucosal Immunol; 2015 Jul; 8(4):918-29. PubMed ID: 25492475
[TBL] [Abstract][Full Text] [Related]
58. DR3 Regulates Intestinal Epithelial Homeostasis and Regeneration After Intestinal Barrier Injury.
Shimodaira Y; More SK; Hamade H; Blackwood AY; Abraham JP; Thomas LS; Miller JH; Stamps DT; Castanon SL; Jacob N; Ha CWY; Devkota S; Shih DQ; Targan SR; Michelsen KS
Cell Mol Gastroenterol Hepatol; 2023; 16(1):83-105. PubMed ID: 37011811
[TBL] [Abstract][Full Text] [Related]
59. Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
Stengel ST; Fazio A; Lipinski S; Jahn MT; Aden K; Ito G; Wottawa F; Kuiper JWP; Coleman OI; Tran F; Bordoni D; Bernardes JP; Jentzsch M; Luzius A; Bierwirth S; Messner B; Henning A; Welz L; Kakavand N; Falk-Paulsen M; Imm S; Hinrichsen F; Zilbauer M; Schreiber S; Kaser A; Blumberg R; Haller D; Rosenstiel P
Gastroenterology; 2020 Oct; 159(4):1357-1374.e10. PubMed ID: 32673694
[TBL] [Abstract][Full Text] [Related]
60. Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion.
Scharl M; Rudenko I; McCole DF
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G935-45. PubMed ID: 20689057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
